Fig. 1From: Genetic deletion of MMP12 ameliorates cardiometabolic disease by improving insulin sensitivity, systemic inflammation, and atherosclerotic features in miceReduced circulating lipid concentrations and improved glucose tolerance and insulin sensitivity in DKO mice. Male LdlrKO and DKO mice were fed HFSC for 16 weeks. (A) Body weight curves (n = 6–7) and (B) tissue weights relative to total body weight (n = 7). (C) Plasma triglyceride (TG), total cholesterol (TC), free cholesterol (FC), and cholesteryl ester (CE) concentrations in 12-h fasted mice (n = 7–9). Lipoprotein profiles of (D) TG and (E) TC in pooled plasma samples (n = 7–9) after fast protein liquid chromatography separation. (F) Plasma glucose concentrations in 12-h fasted mice (n = 6–7) and during (G) oral glucose tolerance (n = 4–6) and (I) insulin tolerance tests (n = 7). Area under the curve (A.U.C) calculated from (H) oral glucose tolerance and (J) insulin tolerance tests. All data represent mean values ± SD. *p < 0.05, **p ≤ 0.01Back to article page